ATLANTA–(BUSINESS WIRE)–Azalea Health, a leading provider of fully-integrated cloud-based healthcare IT solutions and services, announced today Julieann Esper Rainville has joined its board of directors. Rainville is the president of PointClickCare, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights. She was recently ranked number one among The Top 25 Women … [Read more…]

STONY BROOK, N.Y.–(BUSINESS WIRE)–$APDN #LinearDNA—Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in cell-free, enzymatic DNA production, announced the formal launch of business development initiatives to expand the biotherapeutics industry’s awareness of the LinearDNA™ platform (the “platform”) as an alternative to current plasmid-based (pDNA) production processes used in the manufacture of DNA for … [Read more…]

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, today announced new clinical outcomes data and scientific research, showcasing the power behind the company’s platform of Active Intelligence® technologies. The studies were presented at the 2022 International Society for Computer Assisted Orthopaedic Surgery (CAOS) annual meeting. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Neutrophil Elastase Inhibitor – Pipeline Insight, 2022” clinical trials has been added to ResearchAndMarkets.com’s offering. “Neutrophil Elastase Inhibitor – Pipeline Insight, 2022” report offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Neutrophil Elastase Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “US Biosensors Market (2022-2027) by Type, Product, Application, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering. The US Biosensors Market is estimated to be USD 6.49 Bn in 2022 and is projected to reach USD 11.22 Bn by 2027, growing at a CAGR of … [Read more…]

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–#CLIFighters—Reflow Medical, Inc., a California-based medical device company, has completed enrollment in the DEEPER LIMUS clinical trial (NCT04162418) to evaluate the Temporary Spur Stent System, a patented device designed to treat long, diffuse and severely calcified infrapopliteal disease. The system allows for uniform expansion of the stent to maximize lumen diameter and … [Read more…]

This marks the company’s first major step in expanding its unique clinical trial delivery model across the globe BOSTON–(BUSINESS WIRE)–Care Access, the world leader in decentralized clinical trials delivery, today announced the acquisition of Instituto Brasil de Pesquisa Clínica (IBPClin), a clinical trial center in Rio de Janeiro, Brazil, as the first step to bring … [Read more…]

Article highlights promising preliminary results and path forward for FDA-approved stem cell treatment study NEW YORK–(BUSINESS WIRE)–The Tisch Multiple Sclerosis Research Center of New York, the world’s largest independent research center focusing on MS, is proud to announce that its FDA-approved stem cell treatment study was featured in an article in BioSpace. Preliminary analysis of … [Read more…]

Long term follow-up published in International Forum of Allergy & Rhinology demonstrates treatment durability for nasal valve collapse SUNNYVALE, Calif.–(BUSINESS WIRE)–#VivAer—Aerin Medical Inc., a company that provides Ear, Nose and Throat (ENT) physicians with non-invasive solutions to treat chronic nasal conditions, today announced that the International Forum of Allergy & Rhinology published positive four-year results … [Read more…]

HOUSTON–(BUSINESS WIRE)–As older adults continue to age, it can be difficult for both them and their loved ones to distinguish between the signs and symptoms associated with ‘normal’ aging, such as stress and cognitive decline, and a common precursor to dementia called Mild Cognitive Impairment (MCI) – especially when it’s in its very early stages. … [Read more…]